These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23615508)

  • 1. Novel roles of complement in renal diseases and their therapeutic consequences.
    Wada T; Nangaku M
    Kidney Int; 2013 Sep; 84(3):441-50. PubMed ID: 23615508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement and kidney disease.
    Cook HT
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):295-301. PubMed ID: 23508058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement in glomerular diseases.
    Tan Y; Zhao MH
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():11-15. PubMed ID: 30298653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling complement-driven diseases in transgenic mice: Values and limitations.
    Ueda Y; Gullipalli D; Song WC
    Immunobiology; 2016 Oct; 221(10):1080-90. PubMed ID: 27371974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).
    Sethi S; Fervenza FC
    Semin Thromb Hemost; 2014 Jun; 40(4):416-21. PubMed ID: 24799306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.
    Mizuno M; Suzuki Y; Ito Y
    Clin Exp Nephrol; 2018 Feb; 22(1):3-14. PubMed ID: 28341889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatoid arthritis and the complement system.
    Okroj M; Heinegård D; Holmdahl R; Blom AM
    Ann Med; 2007; 39(7):517-30. PubMed ID: 17852027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective complement action and control defines disease pathology for retinal and renal disorders and provides a basis for new therapeutic approaches.
    Zipfel PF; Lauer N
    Adv Exp Med Biol; 2013; 735():173-87. PubMed ID: 23402026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of Complement in Kidney Diseases - New Aspects].
    Zipfel PF; Zipfel S; Wiech T
    Dtsch Med Wochenschr; 2023 Jun; 148(12):774-779. PubMed ID: 37257480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the complement cascade: novel treatments coming down the pike.
    Thurman JM; Le Quintrec M
    Kidney Int; 2016 Oct; 90(4):746-52. PubMed ID: 27325183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement and glomerular diseases.
    Popat RJ; Robson MG
    Nephron Clin Pract; 2014; 128(3-4):238-42. PubMed ID: 25412932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complement system in the pathogenesis and progression of kidney diseases: What doesn't kill you makes you older.
    Stea ED; D'Ettorre G; Mitrotti A; Gesualdo L
    Eur J Intern Med; 2024 Jun; 124():22-31. PubMed ID: 38461065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys.
    Koopman JJE; van Essen MF; Rennke HG; de Vries APJ; van Kooten C
    Front Immunol; 2020; 11():599974. PubMed ID: 33643288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of properdin in complement-mediated kidney diseases.
    van Essen MF; Ruben JM; de Vries APJ; van Kooten C;
    Nephrol Dial Transplant; 2019 May; 34(5):742-750. PubMed ID: 30053164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical approach to children with C3 glomerulopathy.
    Vivarelli M; van de Kar N; Labbadia R; Diomedi-Camassei F; Thurman JM
    Pediatr Nephrol; 2022 Mar; 37(3):521-535. PubMed ID: 34002292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-complement therapy for glomerular diseases.
    Bomback AS
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):152-8. PubMed ID: 24602464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies.
    Diepenhorst GM; van Gulik TM; Hack CE
    Ann Surg; 2009 Jun; 249(6):889-99. PubMed ID: 19474697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement and Complement Targeting Therapies in Glomerular Diseases.
    Andrighetto S; Leventhal J; Zaza G; Cravedi P
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31888179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure.
    Bao L; Wang Y; Chang A; Minto AW; Zhou J; Kang H; Haas M; Quigg RJ
    J Am Soc Nephrol; 2007 Mar; 18(3):811-22. PubMed ID: 17229915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
    Hirt-Minkowski P; Dickenmann M; Schifferli JA
    Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.